Buyer's Choice Awards rely solely on vetted, unbiased customer reviews. To qualify, each product must receive at least 10 reviews between January 1, and October 17, 2025, ensuring fresh, relevant ...
In December 2025, Morningstar, Inc. and its subsidiary PitchBook launched new apps within OpenAI’s ChatGPT, allowing entitled users to access their research, data, and ratings through natural-language ...
Technology companies, especially small ones, have often had difficulty selling their wares to the Pentagon thanks to bureaucratic red tape and excruciatingly slow sales cycles. And the U.S. greatly ...
Morningstar has published an investor Q&A dated December 23, 2025, compiling written responses to shareholder and prospective investor questions received through December 5, 2025, as part of its ...
After several years of constrained liquidity and uneven deal activity, investors are entering 2026 with a blend of realism and optimism. Private equity markets are moving toward a more measured phase ...
PitchBook noted that Q3 2025 cybersecurity investment reached a multiyear low amid shifting enterprise security priorities.
PE dealmaking in healthcare services has declined since 2021 highs, according to PitchBook. Firms began to pull back their investments last year as they faced high interest rates and labor costs, as ...
Venture capital funding for digital health companies has stabilized after a major drop in investment coming out of the COVID-19 pandemic, according to a PitchBook report. Startups raised $1.1 billion ...
PitchBook has recently noted that e-commerce enablement startups made a fairly strong comeback in Q3 2025, securing $3.8 billion.
Finding financial data, particularly for private companies, is no small task. It usually requires a solid BS detector for researching online and a network of knowledgeable sources to bounce numbers ...
The new funding round for Collaborative Robotics was led by General Catalyst and boosts the startup's valuation to more than $500 million.
In this week’s edition of InnovationRx, we look at French healthtech Doctolib’s potential large secondary round, Alice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results